Sustaining Action Against Antimicrobial Resistance : A Case Series of Country Experiences

  19 November 2022

Antimicrobial resistance (AMR) occurs when microbes, bacteria, viruses, fungi, and parasites, evolve in ways that reduce medicine’s ability to fight them. AMR has made many infections, particularly bacterial infections, increasingly difficult or even impossible to treat. Without effective medicines, the number of people with severe microbial infections will increase, as will the number of people who die from these infections. In 2019, 4.95 million deaths were associated with AMR, with the highest AMR-attributable death rates occurring in western sub-Saharan Africa.8 While AMR is a natural evolutionary process that occurs over time, many human-led behaviors have increased its occurrence. The main drivers of AMR include: (1) the misuse and overuse of antimicrobials; (2) lack of access to clean water and adequate sanitation for people and animals; (3) poor infection prevention and control measures in healthcare facilities and farms; (4) limited access to quality, affordable medicines, vaccines, and diagnostics; and (5) lack of awareness and knowledge about AMR. Additionally, for countries to progress from planning to acting, AMR coordination committees must have a clearly defined role and the remit to develop and implement an operational plan. Operational plans should embed NAP activities into the national development agenda, sectoral strategies, and budgets, and should coordinate an aligned approach to delivering NAP activities across sectors and stakeholders. Creating and empowering AMR coordination committees and comprehensively implementing and monitoring the prioritized activities outlined in their NAPs operational plan takes time; but there are several relatively easy entry points for AMR action that countries can utilize to accelerate their fight against AMR. The remaining case studies in this series showcase successful actions against AMR that three countries, Burkina Faso, Jordan, and Malawi, have taken along their journey to fully operationalizing and implementing their NAPs on AMR.

Download the report

Further reading: World Bank
Author(s): World Bank
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed